Abstract
Purpose: Current treatment of autoimmune endogenous posterior uveoretinitis (EPU) is limited by drug toxicity, unpredictable relapses on dose reduction and resistance to therapy. Administration of autoantigens via gastrointestinal or respiratory mucosa prior to antigen exposure induces immune hyporesponsiveness (mucosal tolerance) to further antigen sensitisation. In this study we assessed whether mucosal tolerance induction was possible after immunisation with retinal antigens in experimental autoimmune uveoretinitis (EAU) in animals that were short-term immunosuppressed with cyclosporin A (CsA) to determine whether mucosal administration of retinal antigens can maintain immunosuppression in sensitised and immunosuppressed individuals.
Methods: Female Lewis rats were immunised with retinal extract (RE) and then treated as follows. Group 1 received no specific therapy and served as control; group 2 were fed CsA from day 7 to day 20 post-immunisation; group 3 received inhalational tolerance therapy with RE in addition to CsA; tolerance therapy was continued after day 20 when CsA was stopped. Experiments varying the timing and dosage of both tolerising and immunising antigen were also performed, the details of which are described. Incidence, day of onset and clinical activity were recorded and histopathological assessment of intraocular inflammation, in particular the extent of autoimmune target-organ damage, was graded semiquantitatively.
Results: Compared with controls and group 2, group 3 showed both a marked delay in disease onset and a reduction in disease severity. This effect was both dose and dose-timing dependent. Tissue damage assessed in terms of preservation of rod outer segments was significantly less in group 3.
Conclusions: The success of combination therapy, clinically, remains unknown at present but these results support continuing present clinical trials of mucosal tolerance therapy and in particular have future implications for either maintaining or inducing immunosuppression in autoimmune diseases in combination with present immunosuppressive therapies.
Similar content being viewed by others
Article PDF
References
Forrester JV . Duke Elder Lecture. New concepts on the role of autoimmunity in the pathogenesis of uveitis. Eye 1992; 6: 433–7.
Gery I, Mochizuki M, Nussenblatt RB . Retinal specific antigens and the immunopathologic mechanisms they provoke. Prog Retinal Res 1986; 5: 75–109.
Towler HM, Whiting P, Forrester JV . Combination of low dose CsA and steroid therapy of chronic intraocular inflammation. Eye 1990; 4: 514–20.
Towler HM, Forrester JV, Lightman SL . Low dose CsA therapy of ocular inflammation: preliminary report of a long term follow up study. Autoimmunity 1992; 5: 259–64.
Ishioka M, Ohno S, Nakamura S, Isobe K, Watanabe N, Ishigatsubo Y, Tanaka S . FK 506 treatment of non-infectious uveitis. Am J Ophthalmol 1994; 118: 723–30.
Isaacs J, Dick AD, Haynes RH, Watson P, Meyer PAR, Forrester JV, et al. Monoclonal antibody therapy of chronic intraocular inflammation using CAMPATH-1H. Br J Ophthalmol 1995; 79: 1054–5.
Caspi RR, Roberge FG, McAllister CG, El-Saied M, Kuwabara T, Gery I, Hanna E, Nussenblatt RB . T cell lines mediating experimental autoimmune uveitis in the rat. J Immunol 1986; 136: 928–33.
Dick AD . Retinal antigen-specific T cells mediate experimental autoimmune uveoretinitis (EAU) in PVG rat: a model for tracking antigen-specific CD4+ T cells in the inflamed eye. Ocul Immunol Inflam 1995; 3: 261–70.
Forrester JV, Liversidge J, Dua HS, Towler H, McMenamin PG . Comparison of clinical and experimental uveitis. Curr Eye Res 1990; 9: 75–84.
Dick AD . Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis. Br J Ophthalmol 1995; 79: 81–8.
Forrester JV, Liversidge J, Dua HS, Dick A, Harper F, McMenamin PG . Experimental autoimmune uveoretinitis: a model system for immunosuppression: a review. Curr Eye Res 1992; 11: 33–12.
Nussenblatt RB, Rodrigues MM, Wacker WB, Cevario SJ, Salinas-Camara MC, Gery I . Cyclosporin A: inhibition of experimental autoimmune uveitis in Lewis rat. J Clin Invest 1981; 67: 1228–332.
Nussenblatt RB, Caspi RR, Mahdi R, Chan CC, Roberge F, Lider O, Weiner HL . Inhibition of S-Ag induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1990,144: 1689–95.
Vrabec TR, Gregerson DS, Dua HS, Donoso LA . Inhibition of experimental autoimmune uveoretinitis by oral induction of tolerance with S-Ag and synthetic peptides. Autoimmunity 1992; 12: 175–84.
Lider O, Santos LMB, Lee CYC, Higgens PJ, Weiner HL . Suppression of EAE by oral administration of myelin basic protein: suppression of the disease in vitro immune responses is mediated by antigen-specific CD8+ cells. J Immunol 1988; 142: 748–53.
Thompson HSG, Harper N, Bevan DJ, Staines NA . Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritis responses mediated by active peripheral suppression. Autoimmunity 1993; 16: 189–99.
Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Haffler DA . Double blind pilot trial of oral tolerisation with myelin antigens in multiple sclerosis (see comments). Science 1993; 259: 1321–4.
Holt PG, Sedgwick JD . Suppression of IgE responses following inhalation of antigens. Immunol Today 1987; 8: 14–5.
Dick AD, Cheng Y, Liversidge J, McKinnon A, Forrester JV . Nasal administration of retinal antigens suppresses the inflammatory response in experimental autoimmune uveoretinitis: a preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 1993; 77: 171–9.
Dick AD, Cheng YF, Liversidge J, Forrester JV . Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye 1994; 8: 52–9.
Dick AD, Cheng YF, Liversidge J, Forrester JV . Intranasal administration of retinal antigens suppresses retinal antigen induced experimental autoimmune uveoretinitis. Immunology 1994; 82: 625–31.
Kennedy MK, Tan LJ, DalCanto MC, Tuohy VK, Lu A, Trotter JL, Miller SD . Inhibition of murine relapsing EAE by immune tolerance to proteolipid protein and its encephalogenic peptides. J Immunol 1990; 145: 909–15.
Chen Y, Imobe I, Kichroo VK, Baron JL, Janeway CA Jr, Weiner HL . Oral tolerance in MBP T cell receptor transgenic mice: suppression of autoimmune encepha-lomyelitis and dose dependent induction of regulatory cells. Proc Natl Acad Sci USA 1996; 93: 338–91.
Dick AD, McMenamin PG, Korner H, Scallon BJ, Ghrayeb T, Forrester JV, Sedgwick JD . Inhibition of tumour necrosis factor-activity minimises target-organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol 1996; 26: 1018–25.
Laliotou B, Liversidge J, Forrester JV, Dick AD . Interphotoreceptor retinoid binding protein (IRBP) is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis (EAU) is retinal antigen specific. Br J Ophthalmol 1997; 81: 61–7.
Gregerson DS, Obritsch WF, Donoso LA . Oral tolerance in experimental autoimmune uveoretinitis: distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993; 151: 5751–61.
Sedgwick JD, Holt PG . Induction of IgE-secreting cells and IgE isotype specific suppressor cells in the respiratory tract lymph nodes of rats in response to antigen inhalation. Cell Immunol 1985; 94: 182–90.
Khoury SJ, Hancock WW, Weiner HL . Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176: 1355–64.
Rizzo LV, Miller-Rivero NE, Chan CC, Wiggert B, Nussenblatt RB, Caspi RR . Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J Clin Invest 1994; 94: 1668–72.
Higuchi M, Diamantstein T, Osawa H, Caspi RR . Combined anti-interleukin 2 receptor and low dose cyclosporine therapy in experimental autoimmune uveoretinitis. J Autoimmun 1991; 4(1): 113–24.
McMenamin C, Primm C, McKersey M, Holt PG . Regulation of IgE responses to inhaled antigens in mice by antigen-specific gamma-delta T cells. Science 1994; 265: 1869–70.
Wildner G, Kuhnlein P, Hunig T, Thurau SR . The role of gamma-delta T cells in induction and suppression of experimental autoimmune uveitis. Presented at the Joint European Research Meetings in Ophthalmology and Vision, Montpellier, France, October 1995. Abstract published in Vision Res 1995; 35(Suppl): S113.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kreutzer, B., Laliotou, B., Cheng, Y. et al. Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-a-treated lewis rats: Future treatment of endogenous posterior uveoretinitis?. Eye 11, 445–452 (1997). https://doi.org/10.1038/eye.1997.125
Issue Date:
DOI: https://doi.org/10.1038/eye.1997.125